Expression of Matrix Metalloproteinases Subsequent to UrogenitalChlamydia muridarumInfection of Mice
Authors:
Open Access
- 1 October 2005
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 73 (10) , 7027-7031
Abstract
The central hypothesis of this study was that matrix metalloproteinases (MMPs) would be enhanced following murine chlamydial infection and that their expression would vary in mouse strains that differ in their susceptibility to chronic chlamydia-induced disease. To address this hypothesis, female C3H/HeN and C57BL/6 mice were infected intravaginally withChlamydia muridarum. Uterine and oviduct tissues were assessed for transcription of MMP genes and their tissue inhibitors. An increased activity of MMP genes relative to preinfection tissues was observed in the C3H/HeN mice when compared to C57BL/6 mice. Using gelatin zymography, we detected constitutive MMP-2 activity in both strains of mice but an increase in MMP-9. Casein zymography indicated the presence of two elastase-like activities consistent with MMP-12 and possibly MMP-7. Western blotting and antigen capture enzyme-linked immunoassay also confirmed an increase in MMP-9 but constitutive MMP-2 expression subsequent to the infection in both strains of mice. In C57BL/6 mice, MMP-9 was present in monomer and dimer form throughout the 56-day monitoring period. C3H/HeN mice produced dimeric MMP-9, but increases in the monomer form were also observed through day 14. Post-translational modification of MMP-9 between the two strains also differed. Immunohistochemistry revealed neutrophils as a prominent source for MMP-9 in both strains of mice. We conclude that differences in the relative expression and activity of MMPs, particularly MMP-9, occur in mice differing in their susceptibility to the development of chronic chlamydial disease. These differences may account for disparate outcomes with regard to chronic sequelae of the disease.Keywords
This publication has 51 references indexed in Scilit:
- A Theoretical Model of Type I Collagen Proteolysis by Matrix Metalloproteinase (MMP) 2 and Membrane Type 1 MMP in the Presence of Tissue Inhibitor of Metalloproteinase 2Journal of Biological Chemistry, 2004
- Pro-MMP-9 is a specific macrophage product and is activated by osteoarthritic chondrocytes via MMP-3 or a MT1-MMP/MMP-13 cascadeExperimental Cell Research, 2004
- Biochemistry and Molecular Biology of Gelatinase B or Matrix Metalloproteinase-9 (MMP-9)Critical Reviews in Biochemistry and Molecular Biology, 2002
- Role for Inducible Nitric Oxide Synthase in Protection from ChronicChlamydia trachomatisUrogenital Disease in Mice and Its Regulation by Oxygen Free RadicalsInfection and Immunity, 2001
- Chlamydia trachomatisPersistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection OutcomeInfection and Immunity, 2001
- ESCHERICHIA COLI LIPOPOLYSACCHARIDE POTENTIATION AND INHIBITION OF RAT NEONATAL MICROGLIA SUPEROXIDE ANION GENERATIONShock, 1999
- Collagenases and tissue inhibitors of metalloproteinases: a functional balance in tissue degradationOral Diseases, 1996
- Matrix Metalloproteinase 7 (Matrilysin) from Human Rectal Carcinoma CellsJournal of Biological Chemistry, 1995
- Molecular Cloning and Expression of the Mouse 105-kDa Gelatinase cDNABiochemical and Biophysical Research Communications, 1993
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989